Compare HQ & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HQ | FLGT |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | Singapore | United States |
| Employees | 44 | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 499.5M | 525.3M |
| IPO Year | N/A | 2016 |
| Metric | HQ | FLGT |
|---|---|---|
| Price | $12.22 | $15.94 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $28.33 |
| AVG Volume (30 Days) | 229.2K | ★ 512.2K |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $18,730,000.00 |
| Revenue This Year | N/A | $10.09 |
| Revenue Next Year | N/A | $12.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.29 | $13.46 |
| 52 Week High | $14.22 | $31.04 |
| Indicator | HQ | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 56.65 | 51.68 |
| Support Level | $9.08 | $15.39 |
| Resistance Level | $12.70 | $16.70 |
| Average True Range (ATR) | 1.11 | 0.67 |
| MACD | 0.17 | 0.14 |
| Stochastic Oscillator | 80.29 | 74.59 |
Horizon Quantum Holdings Ltd is building software infrastructure to make quantum computers accessible to commercial enterprises and hardware providers. By bridging the gap between hardware and applications, the company seeks to equip developers, researchers, and enterprises with the quantum software infrastructure needed to solve real-world problems. The company is developing tools that can automatically accelerate code written for conventional computers on quantum computers.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.